Careers
Contact Us
Articles2020-09-14T11:31:03+00:00

Board Announcement – Appointment of new CEO

September 1, 2022|

HORSHAM, UK – 01 SEPTEMBER 2022 – The Board of Veryan Holdings Ltd announces that, following 11 years of service, including 8 years as COO and 3 years as CEO, Nick Yeo has decided to leave Veryan to pursue new professional and personal goals.

Board Announcement – Appointment of new CEO

September 1, 2022|

HORSHAM, UK – 01 SEPTEMBER 2022 – The Board of Veryan Holdings Ltd announces that, following 11 years of service, including 8 years as COO and 3 years as CEO, Nick Yeo has decided to leave Veryan to pursue new professional and personal goals.

Veryan & Otsuka

September 18, 2020|

Who we are Where we're going Our innovative approach Careers Veryan Board Executive Team A day in the ...

The Right Tech

September 18, 2020|

Learn How To Boost Your Revenue With Avada Business Coach Lorem ipsum dolor sit amet, consectetur adipiscing ...

Working Environment

September 18, 2020|

Learn How To Boost Your Revenue With Avada Business Coach Lorem ipsum dolor sit amet, consectetur adipiscing ...

We’re Waiting To Help You

Get in touch with us today and let’s start transforming your business from the ground up.

Book A Consultation

©Veryan Medical 2022   

BioMimics 3D Vascular Stent System has FDA and CE Mark approval.
BioMimics 3D & Swirling Flow Stent are registered trademarks of Veryan Medical Limited.
Veryan Medical Limited is a member of the Otsuka Medical Devices group of companies.
CAUTION: Federal law restricts this device to sale by or on the order of a physician. 

PAM 14 Version 3.0

Go to Top